Ligand validation:6TNP

NO8: (2~{S})-~{N}-[2-[[(2~{S})-1-[[(2~{S},3~{R})-3-[(2~{S},3~{R},4~{R},5~{R},6~{R})-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-1-[[(2~{S})-1-[(2~{S})-2-aminocarbonylpyrrolidin-1-yl]-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-butan-2-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-2-oxidanylidene-ethyl]-1-[(2~{S})-2-azanylpropanoyl]pyrrolidine-2-carboxamide

NO8 is a Ligand Of Interest in 6TNP designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6TNP_NO8_D_201	41%	7%	0.213	0.929	2.73	2.4	18	32	3	0	100%	1
6TNP_NO8_H_201	30%	11%	0.196	0.913	2.3	2.06	9	19	0	0	71%	0.7143
6TNP_NO8_B_201	20%	22%	0.242	0.89	1.83	1.55	7	10	2	0	77%	0.7679
6TNP_NO8_F_201	11%	7%	0.263	0.839	2.56	2.37	9	17	0	0	64%	0.6429
6TNP_NO8_I_201	5%	7%	0.281	0.784	2.56	2.38	11	12	1	0	41%	0.4107

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.